With appreciation for feedback from Mark Fendrick, Director of the Value-Based Insurance Design (V-BID) Center at the ...
The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
Fifteen prescription medications will be the focus of federal price negotiations that could lower prices for Medicare patients.
The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.
MedPage Today on MSN
Botox, Trulicity, and 13 Other Drugs Selected for Medicare Price Negotiation
List includes medications for diabetes, cancer, arthritis, and more ...
The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.
The following information was released by the American Medical Association:. Last week on Jan. 22, five CEOs of the nation's largest health insurers and pharmacy benefit managers appeared before the ...
Still, the medications in the latest round of negotiations — which now includes Part B drugs given in doctor’s offices — draw very limited revenue from Medicare, an analyst pointed out.
Dan Ordyna, CEO, and Mike Hunsaker, COO, from Star Valley Health both stepped into the SVI Radio studio on Monday, February 2. An update was provided regarding the financial status of Star Valley ...
Chutes go first… UnitedHealth Group’s 2025 financials not only triggered a one-day drop in its stock of 19.6% ($282), but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results